an experimental experience

https://www.neurologylive.com/view/solanezumab-fails-a4-alzheimer-study-fda-lifts-hold-freedom-dm1-trial-cms-coverage-pet-amyloid-imaging

+ 104 more

10/21/23 at 11:05am

Organization

Author

NeurologyLive® Staff

Summarize

Neurological Conditions Aging & Geriatrics Health Solanezumab A4 Alzheimer Study PET Amyloid Coverages FDA Lifts Hold on FREEDOM-DM1 Trial Imaging - Neurology Live Neurology News Network

Neurology News Network for the week ending October 21, 2023. [WATCH TIME: 3 minutes]

Create an account or login to join the discussion